Agonist treatment also blocked the increase in serum PRL concentration induced by the dopamine receptor antagonist haloperidol as well as hyperprolactinemia obtained by transplantation of the pituitary under the kidney capsule (155). This evidence concerns the gene PRL and hyperprolactinemia.